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Background/Objectives: Behavioral and psychological symptoms of
dementia (BPSD) are nearly universal in dementia and associated
with multiple negative outcomes. Current real-world manage-
ment is largely pharmacologic, despite poor risk/benefit. The
WeCareAdvisor was designed to enable family caregivers to assess,
manage, and track BPSD using nonpharmacologic strategies.
Design: In-depth qualitative data were collected from family care-
givers of people with dementia to inform: (1) style of approach and
“look and feel” of the tool, and (2) the types of psychoeducation
most needed by caregivers.
Results: We conducted 4 focus groups and a technology survey
(n=26) as well as additional individual semistructured interviews
(n=12) with family caregivers. Main themes of the qualitative
work included: (1) need to minimize difficulty and training time; (2)
importance of “one-stop shopping” for information; and (3)
necessity for information to be tailored to the caregiver and person
with dementia. This information was then combined with effective
existing evidence-based behavioral strategies to create a web-based
tailored caregiver-support tool.
Conclusions: The WeCareAdvisor was designed with input on
functionality and content by end-users, family caregivers. The
randomized controlled trial of WeCareAdvisor will test whether the
tool improves outcomes including caregiver upset and burden and
frequency and severity of BPSD.
Key Words: neuropsychiatric symptoms of dementia, non-
pharmacologic approaches, informal caregivers
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Dementia is a devastating syndrome affecting over 5million people in the United States, and potentially
affecting 16 million people by 2050.1 Although cognitive
impairment is the clinical hallmark of dementia, non-
cognitive behavioral and psychological symptoms of
dementia (BPSD) are exceedingly common (affecting 98%
of individuals at some point in the illness course) and often
dominate disease presentation.2 BPSD including depres-
sion, psychosis, psychomotor agitation, aggression, apathy,
sleep disturbances, and inappropriate behaviors occur in
dementia of all types.3 BPSD seem to be a consequence of
multiple, but sometimes modifiable, interacting factors
internal and external to the person with dementia (PWD)
including patient (eg, undiagnosed medical conditions and
untreated pain), caregiver (eg, ineffective communication
style) and environmental (eg, overstimulation or lack of
activity/structure) factors.4
BPSD, as opposed to core cognitive symptoms, create
the most difficulties for patients, caregivers, and providers,
and commonly lead to earlier nursing home placement.4
Other negative outcomes include excess morbidity, mor-
tality, and hospital stays, caregiver stress and depression,
and reduced caregiver employment income.4 In total, 30%
of the cost of caring for community-dwelling patients with
dementia is directly attributable to BPSD management.5
Managing BPSD is one of the most challenging aspects of
caring for a PWD, causing intense caregiver burden and
upset.6 Caregivers of individuals with BPSD are more dis-
tressed and depressed than those not managing behaviors.7
In real-world settings, few treatment options are cur-
rently available to family caregivers for BPSD. Typically, if
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a caregiver expresses concern about a BPSD to a physician,
a psychiatric medication is prescribed to try to control these
symptoms. However, the FDA has not approved any
medications for BPSD, and the medication class with the
strongest evidence for effect for BPSD, antipsychotics,
demonstrates limited efficacy at best.8 Further, anti-
psychotic use in dementia has been shown to have sig-
nificant risks including mortality9 resulting in FDA black
box warnings. In addition, BPSD can be a “moving target”
with different symptoms appearing over time, and care-
givers frequently managing multiple BPSD simultaneously,
and thus, unpredictability and complexity makes a simple
“magic bullet” medication solution impossible.
In contrast, nonpharmacologic behavioral management
strategies are increasingly recognized as a critical part of
comprehensive, state of the art dementia care.10 Non-
pharmacologic strategies are recommended by multiple
medical organizations and expert groups as the preferred first-
line treatment approach to BPSD, except in emergency sit-
uations when behaviors could lead to imminent danger.10–13
An emerging evidence base supports the use of a range of
nonpharmacologic approaches to manage BPSD. The com-
mon goal of nonpharmacologic approaches is prevention,
symptom relief, and reduction of caregiver distress.
To date, however, only “hands-on” staff-intensive and
training-intensive interventions have been developed and
tested to help families manage BPSD. These approaches have
demonstrated effectiveness, but are time-consuming, labor-
intensive, and intervene for a limited period of time in the
trajectory of a family’s care provision. In addition, unfortu-
nately few of these proven interventions have been translated
into a deliverable and sustainable service, and thus, most
families continue to be underserved or receive services that are
not evidence-based. Although a number of prior studies have
incorporated technology components,14–17 there have been no
web-based, easy to use, comprehensive interactive tools to help
families manage BPSD and track their modifiable underlying
causes such as pain, sleep disturbances, or poor nutrition and
which can be used over the course of the disease.
As part of an NIH-funded project (5R01NR014200),
we sought to overcome this research-practice gap by cre-
ating a tool that would guide caregivers through a clinical
reasoning process to identify, monitor, and manage
behaviors while simultaneously addressing motivation, self-
efficacy and problem-solving skills. This type of approach
has been offered to consumers for management of other
complex health conditions such as cancer, smoking cessa-
tion, weight management, and asthma.18,19
The keystone of the proposed tool was the “DICE”
approach to screen, identify, and manage BPSD that was
developed from a multidisciplinary expert consensus panel.20
DICE is an algorithmic evidence-based approach comprised of 4
steps: DESCRIBE (describe the behavior to derive an accurate
characterization and the context in which it occurs; INVES-
TIGATE (examine, exclude, and identify possible underlying
causes of the behavior); CREATE (create and implement a
treatment plan for the behavior); and EVALUATE (assess what
parts of the treatment plan were attempted and effective). Within
the DICE approach, caregiver (expectations, caregiver stress/
depression, etc); PWD (medical conditions, functional status,
etc.); and environmental (overstimulation, lack of routines, etc.)
considerations are evaluated. We proposed to involve end-users
(eg, family caregivers) in guiding us in the design of a tool
incorporating the DICE approach that would: (1) be easy to use;
(2) be tailored to the PWD’s and caregiver’s specific behavioral
concerns, environment and personal characteristics; (3) teach
new transferrable skills to the end-users; (4) provide an alter-
native to the risks and limited efficacy associated with medi-
cation treatment; and (5) could be used throughout the disease
course.
To assure our approach met the needs of end-users, we
conducted a study consisting of a series of focus groups and in-
depth interviews with family caregivers. The purpose of this
paper is to report the outcomes of these interviews and the
implications for tool development for dementia caregivers.
METHODS
Four focus groups were held with a total of 26 family
caregivers. Study participants for the focus groups were
recruited via 2 methods: (1) by the caregiver responding to fliers
placed at local senior resource centers and contacting research
staff by phone or email; and (2) by referral from senior resource
center staff. Eligible persons were primary caregivers of a person
diagnosed with dementia. Directly before the beginning of the
group meeting, participants provided informed consent and also
completed a brief survey that contained questions regarding: (1)
demographic information; (2) caregiving characteristics; and (3)
technology familiarity. An additional 12 semistructured inter-
views for further detail on tool “look and feel” were purposively
sampled from the focus group sample.
All focus groups were conducted by an experienced
facilitator. Using an outline developed by the investigative
team to ensure systematic coverage of participants’ concerns,
ideas, and experiences, study participants were asked about:
(1) the perceived need for psychoeducation about BPSD and
their management; (2) the language used to describe BPSD; (3)
opinions regarding medication versus behavioral management
for symptoms; and (4) previous experiences and communica-
tion with providers and family members related to BPSD.
Further prompts investigated the caregivers’ understanding of
BPSD’s relationship to the underlying dementing illness (vs.
willful behaviors) and past experiences with symptom treat-
ment. Focus groups provided an opportunity to generate ideas
about treatment preferences, the language to be used in the
tool, and identifying desired tool components which are the
data presented here. Focus group sessions lastedB90 minutes
and were audio-recorded. Sessions were then transcribed and
transcriptions verified for accuracy by research staff.
A qualitative data research expert (D.W.) led the study
team (B.S., M.T., and H.C.K.) in data analysis using a
spreadsheet or “all-inclusive data table” technique to
organize, manage, and analyze the data as a group.21,22 The
spreadsheet consisted of 7 row headings: transcript number,
outline section, question asked, participant response, notes,
code, and theme. The team then used a data reduction
technique called “rigorous and accelerated data reduction”
(RADaR) the purpose of which is to generate results
quickly and meticulously for translation and dissem-
ination.22,23 Working together in Microsoft Excel, the team
placed segments of raw text from the transcripts into the
spreadsheet. Next, a 2-level process was used to code the
data to analyze it for embedded meaning. First, open
coding was used to identify categories, concepts, and
themes germane to the project goals (eg, what would be
most useful for caregivers to see in a tool created to assess
and manage BPSD). Second, the team worked together to
identify the frequency of codes to determine which concepts
were most cited throughout the data. Data from each focus
group were analyzed separately (eg, individual group data
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not initially combined). Although the basic focus group
script questions did not change from the first group to the
other 3 groups, material was added to include additional
probes (the purpose of which is to get more detail for given
questions) if suggested from analysis of prior groups.
RESULTS
Table 1 shows the characteristics of the family care-
givers (n=26) who were involved in the 4 focus groups. The
majority of caregivers were adult children of the PWD, fol-
lowed by spouse as the next most common category and then
by other relative. Mean age of caregiver was 52 years old and
the PWD was 82 years old. Most caregivers were women, had
a college degree or higher, were married and white. Most
caregivers had been providing care for 2 years or more and
were providing >10 hours of care per week to the PWD.
Table 2 depicts caregiver technology familiarity. All had
access to a computer, the internet and email, and most used the
computer several times per day. The majority used multiple
devices (eg, smartphone, desktop, laptop). Top sources from
which participants obtained dementia information were: online
internet searches; Alzheimer’s Association; physician; mag-
azines; and social workers. All but 2 participants expressed
interest in using a web-based program to help with BPSD
management; the 2 who were not interested cited concerns with
“privacy” and “discomfort using computer except for email.”
The primary themes related to tool development from
the focus groups centered on 3 main areas:
(1) Need to minimize difficulty and training time:
 If the tool needs training, it’s too complicated.
 Make it intuitive or you will scare people away. We
are stressed already.
(2) “One-stop shopping” for information:
 Information is all piece meal (on the internet),
nothing is brought together.
 I had a specific question and there was no systematic
way to find an answer. I had to look through topic
threads and hope that someone responded.
(3) The need for tailored output:
TABLE 1. Characteristics of Family Caregivers (n = 26)
Characteristics N (%)
Relationship to care recipient
Adult child 15 (57.7)
Spouse 6 (23.1)
Other relative 5 (19.2)










Never married 2 (7.7)
Widowed 1 (3.8)
Education
High school or less 1 (3.8)
Some college/associate’s degree 5 (19.2)
Bachelor’s degree 11 (42.3)
Graduate degree 9 (34.6)
Time providing care (y)
1 y or less 3 (11.5)
2-3 y 9 (34.6)
4-5 y 7 (26.9)
>5 y 7 (26.9)






Mean age of care recipient (y) 82 (61-96)







Few times a month or less 1 (3.8)
Once a week 0 (0)
Every day or 2 6 (23.1)
Several times per day 19 (73.1)










Few times a month or less 1 (3.8)
Once a week 0 (0)
Every day or 2 8 (30.1)
Several times per day 17 (65.4)
Internet access
Yes 26 (100)





Multiple devices 18 (69.2)
Internet access frequency
Few times a month or less 0 (0)
Once a week 0 (0)
Every day or 2 8 (30.1)
Several times per day 18 (69.2)
Dementia caregiving information source (subjects selected all that
applied)
Alzheimer’s association 19 (73.1)
Physician 15 (57.7)










*“No” response reflected concerns for privacy (1 subject) and comfort in
only using the computer for email (1 subject).
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FIGURE 1. (continued)
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 I’m going to strangle somebody if I see a frequently
asked questions, I can’t be put into one category.
 One of my frustrations about support groups is the
disparity in the kind of issues people are dealing with.
Caregivers also gave feedback about specific features
they would like to see included in the proposed tool:
 It would have arms and legs (eg, human touches).
 Contain strategies on how to speak with someone who is
confused and upset.
 Provide an understanding of how medical problems like
urinary tract infections cause behaviors.
 It would be great to get an email each day with some
words of encouragement y to ground you, give you
strength and energy to keep doing what you are doing.
FIGURE 1. (continued)
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 It would be nice to have a little search engine to put in
whatever you are dealing with and it pops up some strategies.
 Build in feedback so the user can say ‘this didn’t work’.
 I would like things [ideas] for taking care of me, the
caregiver. When I am feeling thus and so to know that this is
part of the game and ideas of how to get out of that mode.
In the semistructured interviews (n=12), we received
additional feedback on the tool in several areas: (1) naming
of tool sections (eg, Caregiver Survival Guide preferred
over Caregiver College and Caregiver Corner for section on
education); (2) suggestions for types of education included
in the tool (eg, material on medication side effects); (3)
types of graphics that would be appealing (eg, caregivers
preferred a horizontal graded pain scale over a face scale:
“these things are childish” or a vertical “thermometer”
scale: “reminds me of heat and raging”); and (4) wording of
the strategies contained in the tool.
Screenshots from the completed WeCareAdvisor tool
are contained in Figure 1. WeCareAdvisor has 2 main
sections:
(1) A guided DICE approach (Fig. 1A) where the caregiver
inputs contextual factors associated with a given BPSD,
including consideration of possible medical illnesses and
pain. The contextual factors (examples of context
screens shown in Figs. 1a.2, Fig. 1a.3) allow the algo-
rithm to select from over 900 strategies that were
included in the tool and help to create the BPSD
“prescription” (Fig. 1a.4) that can be printed or emailed
to others. After using the prescription for 1 week,
caregivers are prompted to evaluate how the tips
worked for them. The strategies included in the tool are
based upon effective evidence-based interventions for
family caregivers. During the DICE process within the
tool, depending upon the type of behavior selected and
contextual variables (eg, is sleep impacted? Is there
underlying pain or a possible medical cause? Is the onset
acute? Is the environment over or understimulating?),
the program selects the strategies that are most likely to
be helpful to the PWD and caregiver. Selection rules for
the algorithm within the tool were developed by one
member of the team (H.C.K.), and then reviewed and
checked by another team member (L.N.G.). Incon-
sistencies were then discussed and the approach tested
independently on multiple occasions by 4 team mem-
bers (H.C.K., L.N.G., B.S., K.M.).
(2) The Caregiver Survival Guide (Fig. 1B) which is a
compendium of information for dementia caregivers
(eg, “one-stop shopping”) that they can read when time
allows with chapters on “what is dementia”; “behaviors
in dementia”; “keeping a person with dementia
healthy”; “communicating with the healthcare team”;
“medications for BPSD: uses and common side effects”;
“keeping a person with dementia safe”; “taking care of
yourself”; “financial matters”; glossary of commonly
used terms in aging and dementia; and other links and
resources. Strategies for managing BPSD that get tail-
ored in the DICE approach also appear in the Caregiver
Survival Guide where they are listed under behavior
type (eg, agitation, aggression, depression, etc).
Caregiver feedback was used in creating many of the
features of the tool, including:
 A daily messaging feature that provides an encouraging
daily communication to caregivers for support and
motivation.
 A peer navigator (Fig. 1a.1; tailored to the age, race, and
sex of the caregiver user) to describe the features of the
tool to the caregiver to “humanize” the experience.
 Incorporating teaching into the tool’s approach (eg,
DICE pain screen shown in Fig. 1a.3 teaches how to
assess for pain in people with dementia) to “minimize
time/training.”
 A notes section where caregivers can write notes to
themselves about care issues that they wish to discuss
with other members of the health care team.
FIGURE 1. A, Guided DICE approach. Selected screens shown. B, Caregiver Survival Guide contents and sample content.
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Because the consideration of urgent situations from a
safety and risk standpoint is a significant concern in
assessing and managing BPSD (an area lacking with many
of the currently used psychosocial approaches), assessment
of safety and potential risk is purposefully built into the
WeCareAdvisor at multiple levels. First, caregiver and
PWD safety and risk is assessed in every DICE session. If
the caregiver indicates any risk to either self or PWD, one
of the strategies that will appear in the DICE prescription
will be a clear recommendation for the caregiver to seek
help from the PWD’s physician. For serious risk, something
like the following would be included in the DICE
prescription:
 If Frank’s behavior is putting you or him in danger, talk
to his doctor. There are medications that will not “cure”
the behavior, but can help to calm him down in an
emergency situation.
Secondly, caregivers are asked about potential medical
contributors to BPSD in multiple ways during DICE ses-
sions including: (1) changes in chronic medical conditions
they have listed; (2) the appearance of new symptoms
suggesting delirium (eg, behaviors starting suddenly or
worsening at night); and (3) consideration of pain as a
contributor. If any of these items are noted by the caregiver,
something like the following would be included in the
prescription.
 You have indicated that the behavior may have had a
sudden onset or other characteristics that could suggest a
medical problem underlying the behavior. Please check
with Elizabeth’s doctor for a review of possible medical
causes of the behavior you are seeing.
 You have indicated that Howard has recently taken a
new prescribed medication or there has been a recent
change in medication or its dosing. Medication additions
or changes can trigger behaviors. Please check with his
doctor to see if the behavior could be a medication side
effect.
 You have indicated that Dorothy has a new physical
symptom that started around the same time as the
behavior. Please check with her doctor to see if the
behavior could have been triggered by this new medical
problem. Treating the medical problem may alleviate the
behavior.
 Mild pain can often be managed at home after you talk
to your doctor. First, try to localize figure the source of
the pain (eg, is it a headache? Was Walter sitting too long
in one position? Could he be constipated?). The treat-
ment depends on the source of the pain. If the pain is due
to Walter sitting too long in one position, try to
introduce an active time into his daily routine. If the
pain is from a headache, Walter’s doctor might
recommend Tylenol. For constipation, the doctor may
recommend increasing fluids and fiber in the diet and
stool softeners.
DISCUSSION
In real-world settings, few treatment options are cur-
rently available to family caregivers for BPSD despite a
growing evidence base for the effectiveness of non-
pharmacological strategies. We sought to overcome this
research-practice gap by creating a tool that would guide
caregivers through a clinical reasoning process to identify,
monitor, and manage behaviors while simultaneously
addressing motivation, self-efficacy, and problem-solving
skills.
The tool created, the WeCareAdvisor, builds upon the
DICE approach for BPSD assessment and management
that was created by a multidisciplinary expert panel.20 In
addition to DICE, the tool was “built” with direct input
from the intended end-users, family caregivers. We included
the features that caregivers told us that they wanted
including comprehensive information on dementia and
related issues; daily messaging for encouragement; and
“human” touches.
In the final part of the project, we are testing the
WeCareAdvisor tool in a randomized controlled trial of 60
family caregiver/PWD dyads. We will evaluate the effects of
WeCareAdvisor on the primary outcomes of caregiver
confidence and upset in the treatment group (30 dyads)
compared with the waitlist control group (30 dyads) after
one month of tool use. In addition, we will be collecting
data on other caregiver (stress level, change in negative
communications, perceived change of well-being) and
patient outcomes (behavioral symptom frequency and
severity). Dyads randomized to the waitlist condition will
receive the tool after a 1-month delay, and will be retested 1
month later to evaluate whether they benefit on same
indicators as the initial WeCareAdvisor group. This design
will yield a total of 60 dyads to evaluate WeCareAdvisor
use parameters, including: ease and frequency of use, time
required to learn, and length of time engaged in using the
tool, overall usability, and perceived benefit.
As the WeCareAdvisor is currently being testing in the
NIH-sponsored randomized controlled trial, it is not yet
available to the public. When the trial is completed and
results are reported (estimated as December 2016), we
anticipate making the tool available to family caregivers at
a low cost (under $20) which would enable them to have
ongoing access to the online platform. The fee would be
intended to offset our costs for maintaining and updating
the online program. Costs could be reduced further in
partnership with state, foundation, or private donor fund-
ing that will be sought during development of the com-
mercial product.
Our approach to tool development highlights the value
of including end-users in the process. We obtained critical
and invaluable insight which directly informed tool con-
struction. Online programs for dementia must be respon-
sive to the needs of caregivers and reflect their values
including ease of use, on-demand/easily understood mate-
rials, one-stop shopping, relevance across disease tra-
jectory, and tailoring to their particular context.
Limitations of the research described include the limited
number as well as the relative homogeneity of the caregivers
(in terms of geographical area, race, sex, and education level
in particular) interviewed. In the trial as well as in future
research, we will be determining what iterative changes may
be necessary for more diverse populations (such as in our
current Department of Defense grant with families of military
veterans with dementia, and in a planned larger RCT within
a competing renewal of the current family caregiver grant). In
addition, the sample was also fairly technologically savvy in
terms of the ubiquity of using computers, smartphones, and
the internet. In our current trial, we are limiting recruitment
to caregivers who have some experience with such technology
as we did not wish to test caregivers’ ability to use technology
in general, but rather the use of this particular web-based
program. Moving forward, we will examine how to provide
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less technology savvy caregivers access to the information
and support they need.
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